About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3850440
Allelic
Composition
Cdkn2atm2Brn/Cdkn2atm2Brn
Nf2tm2Gth/Nf2tm2Gth
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn2atm2Brn mutation (2 available); any Cdkn2a mutation (62 available)
Nf2tm2Gth mutation (3 available); any Nf2 mutation (65 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• following adenoviral cre treatment, median survival time is 220 days

neoplasm
• following adenoviral cre treatment, 83% of mice develop highly invasive thoracic tumors (including malignant mesotheliomas, 45 of 57; rhabdomyosarcomas, 3 of 57; and schwannomas, 1 of 57)
• following adenoviral cre treatment, mice develop hepatomegaly either due to oval cell hyperplasia, cholangio-carcinomas and/or hepatomas, and leiomyomas of the uterus
• following adenoviral cre treatment, 4% of mice develop aspecific tumors not induced by adeno-cre treatment
• following adenoviral cre treatment, 70% of mice develop aggressive malignant mesotheliomas, which is higher than in mice carrying other combinations of Cdkn2atm2Brn, Nf2tm2Gth, and Trp53tm1Brn alleles
• in 4% of mice following adenoviral cre treatment
• following adenoviral cre treatment, 7% mice develop monocytic myeloid leukemias

liver/biliary system
• following adenoviral cre treatment, 42% of mice develop hepatomegaly either due to oval cell hyperplasia, cholangio-carcinomas and/or hepatomas, and leiomyomas of the uterus

reproductive system
• in 4% of mice following adenoviral cre treatment

muscle
• in 4% of mice following adenoviral cre treatment

growth/size/body
• following adenoviral cre treatment, 42% of mice develop hepatomegaly either due to oval cell hyperplasia, cholangio-carcinomas and/or hepatomas, and leiomyomas of the uterus

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
malignant mesothelioma DOID:1790 OMIM:156240
J:132943


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/12/2024
MGI 6.23
The Jackson Laboratory